A Cardiovascular Risk Optimization Program in People With Schizophrenia: A Pilot Randomized Controlled Clinical Trial

BACKGROUND: Cardiovascular disease is one of the leading causes of premature death in people with schizophrenia. Some modifiable factors that have been implicated include unhealthy lifestyle, medication side effects, and physical comorbidities. The goal of this study was to assess the efficacy of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Riera-Molist, Núria, Assens-Tauste, Montse, Roura-Poch, Pere, Guimerà-Gallent, Marta, Santos-López, Josep Manel, Serra-Millas, Montserrat, Frau-Rosselló, Neus, Gallego-Peña, Estefania, Foguet-Boreu, Quintí
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631505/
https://www.ncbi.nlm.nih.gov/pubmed/37948170
http://dx.doi.org/10.1097/PRA.0000000000000743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631505/
https://www.ncbi.nlm.nih.gov/pubmed/37948170
http://dx.doi.org/10.1097/PRA.0000000000000743

Ejemplares similares